Lilly France
Lilly France is a major industrial player since 1962, committed to pharmaceutical innovation and serving patients' health needs. The company aims to address public health challenges of the 21st century, promote diversity and inclusion, and uphold environmental responsibility. Lilly France develops and manufactures medications across various therapeutic areas, including diabetes, oncology, dermatology, and more. The company also emphasizes social engagement, environmental sustainability, and responsible corporate practices.
Industries
Nr. of Employees
Very Large (1000+)
Lilly France
Indianapolis, Indiana, United States, North America
Products
Pre‑filled auto‑injector pens and injection device platforms
Prefilled injection pen devices and pen injectors intended for subcutaneous administration; associated clinician/patient instructions and training materials.
Pharmaceutical product portfolio across multiple therapeutic areas
Commercial medicines for therapeutic areas including diabetes, oncology, immunology, endocrinology and neurology (product listings and professional resources).
Pre‑filled auto‑injector pens and injection device platforms
Prefilled injection pen devices and pen injectors intended for subcutaneous administration; associated clinician/patient instructions and training materials.
Pharmaceutical product portfolio across multiple therapeutic areas
Commercial medicines for therapeutic areas including diabetes, oncology, immunology, endocrinology and neurology (product listings and professional resources).
Services
Provision of medical information via phone, email and online channels for questions about medicines and product use.
Systems and contacts to collect and manage adverse event reports, including an online reporting form.
Tool to assess excursions in product storage/transport temperature and help manage cold‑chain incidents.
Provision of medical information via phone, email and online channels for questions about medicines and product use.
Systems and contacts to collect and manage adverse event reports, including an online reporting form.
Tool to assess excursions in product storage/transport temperature and help manage cold‑chain incidents.
Expertise Areas
- Clinical trial management
- Pharmacovigilance and patient safety
- Biologics and sterile drug manufacturing
- Medical device (auto‑injector) manufacturing
Key Technologies
- Sterile filling and device assembly
- Biologic (protein) production
- Temperature‑controlled logistics (cold chain)
- Electronic adverse event reporting systems
News & Updates
Lilly France has set ambitious environmental objectives for 2030, including energy, water, CO2, and waste reduction.
Over 20,000 m² of solar panels installed to achieve 100% green electricity at the site.
Lilly France promotes diversity and inclusion within its corporate culture.
The company emphasizes waste valorization, recycling, and proper disposal of medical waste.
Lilly France aims to be at the forefront of addressing major health issues through innovation and partnerships.
The company integrates environmental, social, and governance practices into its operations.
Lilly France has set ambitious environmental objectives for 2030, including energy, water, CO2, and waste reduction.
Over 20,000 m² of solar panels installed to achieve 100% green electricity at the site.
Lilly France promotes diversity and inclusion within its corporate culture.
The company emphasizes waste valorization, recycling, and proper disposal of medical waste.
Lilly France aims to be at the forefront of addressing major health issues through innovation and partnerships.
The company integrates environmental, social, and governance practices into its operations.